S. Loibl
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 5
-
- Ovarian cancer diagnosis and treatment 10
- Co-authors
- Jens Huober (9 shared papers)Gϋnter von Minckwitz (7 shared papers)Barbara Schmalfeldt (3 shared papers)Valentina Nekljudova (8 shared papers)Hans‐Joachim Lück (2 shared papers)Carsten Denkert (6 shared papers)Andreas du Bois (7 shared papers)M. Gropp (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Annals of Oncology (6 papers)ESMO Open (4 papers)International Journal of Gynecological Cancer (2 papers)Gynecologic Oncology (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
S. Loibl
31 papers receiving 525 citations
Peers
Comparison fields: 5 of 57
- Reproductive Medicine 186
- Oncology 207
- Obstetrics and Gynecology 49
- Cancer Research 69
- Pulmonary and Respiratory Medicine 95
Countries citing papers authored by S. Loibl
This map shows the geographic impact of S. Loibl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Loibl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Loibl more than expected).
Fields of papers citing papers by S. Loibl
This network shows the impact of papers produced by S. Loibl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Loibl. The network helps show where S. Loibl may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Loibl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 146 | |
| 2 | 2009 | 94 | |
| 3 | 2006 | 67 | |
| 4 | 2011 | 42 | |
| 5 | 2005 | 35 | |
| 6 | 2011 | 23 | |
| 7 | 2005 | 20 | |
| 8 | 2009 | 16 | |
| 9 | 2004 | 13 | |
| 10 | 2004 | 13 | |
| 11 | 2022 | 10 | |
| 12 | 2025 | 7 | |
| 13 | 2022 | 7 | |
| 14 | 2007 | 6 | |
| 15 | 2005 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2025 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2003 | 3 | |
| 20 | 2006 | 2 |
About S. Loibl
S. Loibl is a scholar working on Oncology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Obstetrics and Gynecology, having authored 31 papers that have together received 532 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (5 papers), Advanced Breast Cancer Therapies (4 papers), Breast Cancer Treatment Studies (4 papers), Endometrial and Cervical Cancer Treatments (4 papers), Estrogen and related hormone effects (3 papers) and Intraperitoneal and Appendiceal Malignancies (3 papers). The work is most often cited by research in Reproductive Medicine (186 citations), Oncology (207 citations), Obstetrics and Gynecology (49 citations), Cancer Research (69 citations) and Pulmonary and Respiratory Medicine (95 citations). S. Loibl has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Jens Huober, Gϋnter von Minckwitz, Barbara Schmalfeldt, Valentina Nekljudova, Hans‐Joachim Lück, Carsten Denkert, Andreas du Bois, M. Gropp, Michael Untch and Christos Sotiriou. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, ESMO Open, International Journal of Gynecological Cancer and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.